MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteins

Julia Alles, Nicole Ludwig, Stefanie Rheinheimer, Petra Leidinger, Friedrich A. Grässer, Andreas Keller and Eckart Meese

Oncotarget, 2017, 8, 56417
DOI: 10.18632/oncotarget.17662

Small ncRNA-Seq Results of Human Tissues: Variations Depending on Sample Integrity

Nicole Ludwig, Tobias Fehlmann, Valentina Galata, Andre Franke, Christina Backes, Eckart Meese and Andreas Keller

Clinical Chemistry, 2018, 64, 1074
DOI: 10.1373/clinchem.2017.285767

Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma

Jun Wang, Zhi Li, Qinyu Ge, Weibing Wu, Quan Zhu, Jinhua Luo and Liang Chen

The Journal of Thoracic and Cardiovascular Surgery, 2015, 149, 1404
DOI: 10.1016/j.jtcvs.2015.02.012

Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies

Viswam S. Nair, Colin C. Pritchard, Muneesh Tewari and John P. A. Ioannidis

American Journal of Epidemiology, 2014, 180, 140
DOI: 10.1093/aje/kwu135

The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases

Petra Leidinger, Christina Backes, Michael Blatt, Andreas Keller, Hanno Huwer, Philipp Lepper, Robert Bals and Eckart Meese

Mol Cancer, 2014, 13, 202
DOI: 10.1186/1476-4598-13-202

Whole blood microRNA expression may not be useful for screening non-small cell lung cancer

Santosh K. Patnaik, Eric D. Kannisto, Reema Mallick, Anil Vachani, Sai Yendamuri and Bernard Mari

PLoS ONE, 2017, 12, e0181926
DOI: 10.1371/journal.pone.0181926

Current and Future Development in Lung Cancer Diagnosis

Reem Nooreldeen and Horacio Bach

IJMS, 2021, 22, 8661
DOI: 10.3390/ijms22168661

Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model

Tian Zhong, Xingren Liu, Hongmin Li and Jing Zhang

Drug Delivery, 2021, 28, 2108
DOI: 10.1080/10717544.2021.1979129

Genome-wide profiling of transfer RNAs and their role as novel prognostic markers for breast cancer

Preethi Krishnan, Sunita Ghosh, Bo Wang, Mieke Heyns, Dongping Li, John R. Mackey, Olga Kovalchuk and Sambasivarao Damaraju

Sci Rep, 2016, 6
DOI: 10.1038/srep32843

New Insights Into Platelet-enriched miRNAs: Production, Functions, Roles in Tumors, and Potential Targets for Tumor Diagnosis and Treatment

Shuo Miao, Qingsong Zhang, Wenguang Chang and Jianxun Wang

Molecular Cancer Therapeutics, 2021, 20, 1359
DOI: 10.1158/1535-7163.MCT-21-0050

Next-Generation Sequencing: From Understanding Biology to Personalized Medicine

Karen Frese, Hugo Katus and Benjamin Meder

Biology, 2013, 2, 378
DOI: 10.3390/biology2010378

Peregrine

Stanley A. Langevin, Zachary W. Bent, Owen D. Solberg, Deanna J. Curtis, Pamela D. Lane, Kelly P. Williams, Joseph S. Schoeniger, Anupama Sinha, Todd W. Lane and Steven S. Branda

RNA Biology, 2013, 10, 502
DOI: 10.4161/rna.24284

Identification and characterization of microRNAs expressed in the African malaria vector Anopheles funestus life stages using high throughput sequencing

Mushal Allam, Belinda L. Spillings, Hiba Abdalla, Darlington Mapiye, Lizette L. Koekemoer and Alan Christoffels

Malar J, 2016, 15
DOI: 10.1186/s12936-016-1591-0

Next-Generation Sequencing for Lung Cancer

Kehua Wu, R Stephanie Huang, Larry House and William Chi Cho

Future Oncol., 2013, 9, 1323
DOI: 10.2217/fon.13.102

The Potential of Genome-Wide Analyses to Improve Non-Small-Cell Lung Cancer Care

Casey M Wright, Ian A Yang, Rayleen V Bowman and Kwun M Fong

Lung Cancer Manag., 2014, 3, 383
DOI: 10.2217/lmt.14.31

The Role of Non-coding RNAs in Oncology

Frank J. Slack and Arul M. Chinnaiyan

Cell, 2019, 179, 1033
DOI: 10.1016/j.cell.2019.10.017

Principal Component Analysis Based Feature Extraction Approach to Identify Circulating microRNA Biomarkers

Y-h. Taguchi, Yoshiki Murakami and Rossella Rota

PLoS ONE, 2013, 8, e66714
DOI: 10.1371/journal.pone.0066714

Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease

Matthias Hübenthal, Georg Hemmrich-Stanisak, Frauke Degenhardt, Silke Szymczak, Zhipei Du, Abdou Elsharawy, Andreas Keller, Stefan Schreiber, Andre Franke and Mathias Chamaillard

PLoS ONE, 2015, 10, e0140155
DOI: 10.1371/journal.pone.0140155

MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients

Samar A. Mansour, Amgad A. Farhat, Ayman H. Abd El-Zaher, Adel S. Bediwy, Said M. Abdou, Ayman A. Al Saka and Abdel Aziz A. Zidan

Egypt J Bronchol, 2020, 14
DOI: 10.1186/s43168-020-00021-2

cPAS-based sequencing on the BGISEQ-500 to explore small non-coding RNAs

Tobias Fehlmann, Stefanie Reinheimer, Chunyu Geng, Xiaoshan Su, Snezana Drmanac, Andrei Alexeev, Chunyan Zhang, Christina Backes, Nicole Ludwig, Martin Hart, Dan An, Zhenzhen Zhu, Chongjun Xu, Ao Chen, Ming Ni, Jian Liu, Yuxiang Li, Matthew Poulter, Yongping Li, Cord Stähler, Radoje Drmanac, Xun Xu, Eckart Meese and Andreas Keller

Clin Epigenet, 2016, 8
DOI: 10.1186/s13148-016-0287-1

miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2–Versican Pathway

Mohamed Salem, Jacob A. O'Brien, Stefanie Bernaudo, Heba Shawer, Gang Ye, Jelena Brkić, Asma Amleh, Barbara C. Vanderhyden, Basel Refky, Burton B. Yang, Sergey N. Krylov and Chun Peng

Cancer Research, 2018, 78, 4175
DOI: 10.1158/0008-5472.CAN-17-3014

What makes a blood cell based miRNA expression pattern disease specific? - A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls

Petra Leidinger, Christina Backes, Indra N. Dahmke, Valentina Galata, Hanno Huwer, Ingo Stehle, Robert Bals, Andreas Keller and Eckart Meese

Oncotarget, 2014, 5, 9484
DOI: 10.18632/oncotarget.2419

Deep Sequencing Identification of Novel Glucocorticoid-Responsive miRNAs in Apoptotic Primary Lymphocytes

Lindsay K. Smith, Arpit Tandon, Ruchir R. Shah, Deepak Mav, Alyson B. Scoltock, John A. Cidlowski and Zhengqi Wang

PLoS ONE, 2013, 8, e78316
DOI: 10.1371/journal.pone.0078316

Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era

John F Brothers, Kahkeshan Hijazi, Celine Mascaux, Randa A El-Zein, Margaret R Spitz and Avrum Spira

BMC Med, 2013, 11
DOI: 10.1186/1741-7015-11-168

Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinoma

Iben Daugaard, Morten T. Venø, Yan Yan, Tina E. Kjeldsen, Philippe Lamy, Henrik Hager, Jørgen Kjems and Lise Lotte Hansen

Oncotarget, 2017, 8, 27047
DOI: 10.18632/oncotarget.15968

Synergic Fabrication of Naringin Molecule into Polymeric Nanoparticles for the Treatment and Nursing Care of Lung Cancer Therapy

Lingqiao Yan, Hui Chen and Mindan Xie

J Polym Environ, 2021, 29, 4048
DOI: 10.1007/s10924-021-02151-0

MicroRNA Expression Signatures in Solid Malignancies

Marco Galasso, Sukhinder K. Sandhu and Stefano Volinia

The Cancer Journal, 2012, 18, 238
DOI: 10.1097/PPO.0b013e318258b5f4

Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications

Zahra Sadat Hashemi, Saeed Khalili, Mehdi Forouzandeh Moghadam and Esmaeil Sadroddiny

Expert Review of Respiratory Medicine, 2017, 11, 147
DOI: 10.1080/17476348.2017.1279403

Glucose depletion activates mmu-miR-466h-5p expression through oxidative stress and inhibition of histone deacetylation

A. Druz, M. Betenbaugh and J. Shiloach

Nucleic Acids Research, 2012, 40, 7291
DOI: 10.1093/nar/gks452

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma

Michela Bottani, Giuseppe Banfi and Giovanni Lombardi

JCM, 2019, 8, 1661
DOI: 10.3390/jcm8101661

MicroRNAs as lung cancer biomarkers

Valerio Del Vescovo

WJCO, 2014, 5, 604
DOI: 10.5306/wjco.v5.i4.604

miRNA Detection Methods and Clinical Implications in Lung Cancer

Marta Usó, Eloisa Jantus-Lewintre, Rafael Sirera, Roy M Bremnes and Carlos Camps

Future Oncol., 2014, 10, 2279
DOI: 10.2217/fon.14.93

MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction

Solenne Paiva and Onnik Agbulut

Front. Cardiovasc. Med., 2017, 4
DOI: 10.3389/fcvm.2017.00073

Characterization of microRNA transcriptome in lung cancer by next‐generation deep sequencing

Jie Ma, Kaiissar Mannoor, Lu Gao, Afang Tan, Maria A. Guarnera, Min Zhan, Amol Shetty, Sanford A. Stass, Lingxiao Xing and Feng Jiang

Molecular Oncology, 2014, 8, 1208
DOI: 10.1016/j.molonc.2014.03.019

Expression of miR-590 in lung cancer and its correlation with prognosis

Zhifeng Ma, Yaoqin Wang, Binjun He, Jian Cui, Chu Zhang, Haiyong Wang, Weizhong Feng, Bin Wang, Desheng Wei, Yuanlin Wu, Yong Zeng and Guangmao Yu

Oncol Lett, 2017
DOI: 10.3892/ol.2017.7497

Tissue‐specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non‐small cell lung cancer

Qiang Pu, Yuchuan Huang, Yanrong Lu, Yong Peng, Jie Zhang, Guanglin Feng, Changguo Wang, Lunxu Liu and Ya Dai

Thoracic Cancer, 2016, 7, 348
DOI: 10.1111/1759-7714.12317

WITHDRAWN: MicroRNA-505 modulates cancer proliferation and migration in human non-small cell lung cancer through inverse regulation of FZD4

Hong Li, Tian Yang, Qian Ning, Dong Shang, Yan Yao and Zhongmin Sun

Lung Cancer, 2017
DOI: 10.1016/j.lungcan.2017.03.016

miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC

Dong Yang, Jian-Jun Wang, Jin-Song Li and Qian-Yu Xu

oncol res, 2018, 26, 519
DOI: 10.3727/096504017X15000757094686

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing

Andreas Keller, Petra Leidinger, Florian Steinmeyer, Cord Stähler, Andre Franke, Georg Hemmrich-Stanisak, Andreas Kappel, Ian Wright, Jan Dörr, Friedemann Paul, Ricarda Diem, Beatrice Tocariu-Krick, Benjamin Meder, Christina Backes, Eckart Meese and Klemens Ruprecht

Mult Scler, 2014, 20, 295
DOI: 10.1177/1352458513496343

Proteomic Biomarkers for Lung Cancer Progression

Yanjiao Ren, Shishun Zhao, Dandan Jiang, Xin Feng, Yexian Zhang, Zhipeng Wei, Zhongyu Wang, Wenniu Zhang, Qing F Zhou, Yong Li, Hanxu Hou, Ying Xu and Fengfeng Zhou

Biomark. Med., 2018, 12, 205
DOI: 10.2217/bmm-2018-0015